| Intervention | NMA OR (95% CrI) | NMA LogOR (95% CrI) | Number of studies providing direct evidence |
|---|---|---|---|
| Ergometrine | 0.000 (0.000, 0.692) | −25.12 (−70.43, −0.3677) | - |
| Misoprostol plus oxytocin | 0.262 (0.005, 9.459) | −1.339 (−5.293, 2.247) | - |
| Oxytocin >5 IU and ≤ 10 IU | 0.711 (0.081, 7.721) | −0.3406 (−2.518, 2.044) | - |
| Carbetocin | 0.746 (0.081, 8.542) | −0.2936 (−2.513, 2.145) | - |
| Misoprostol ≤ 600 mcg | 0.950 (0.118, 9.217) | −0.05112 (−2.141, 2.221) | 1 |
| Ergometrine plus oxytocin | 7.13E+10 (0.925, 9.80E+30) | 24.99 (−0.07789, 71.36) | - |
Results from the random effects NMA. OR<1 favours the intervention (lower risk of ICU admission in the intervention arm, with lower numbers indicating a greater effect), OR>1 favours placebo. Abbreviations: OR, odds ratio; CrI, credible interval.
From: Evidence reviews for uterotonics for the prevention of postpartum haemorrhage
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.